2Radermecker RP, Renard E, Seheen AJ. Circulating insulin antibod- ies:influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control [ J ]. Diabetes Metab Res Rev,2009,25 (6) :491-501.
3Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[ Jl. N Engl J Med,2010,362(12) :1090-1101.
4Erzofsky JA, Berkower I J, Epstein SL. Antigen-antibody interactions and monoelonal antibodies [ M ]//Paul WE Fundamental immunolo- gy. Philadelphia: Lippincott-Raven Publishers, 1999:75-110.
5Koyama R, Nakanishi K, Kato M, et al. Hypoglycemia and hypergly- cemia due to insulin antibodies against therapeutic human insulin: treatment with double filtration plasmapheresis and prednisolone [ J ]. Am J Med Sci,2005,329 (5) :259-264.
6Matsuyoshi A, Shimoda S, Tsurnzoe K, et al. A case of slowly pro- gressive type 1 diabetes with unstable glycemic control caused by un- usual insulin antibody and successfully treated with steroid therapy [ J]. Diabetes Res Clin Pract ,2006,72 ( 3 ) :238-243.
7Zhao TY, Li F, Xiong ZY. Frequent reoccurrence of hypoglycemia in a type 2 diabetic patient with insulin antibodies [ J ]. Mol Diagn T- her,2010,14 (4) :237-241.
8Tamura Y, Kimbara Y, Funatsuki S, et al. A case of insulin antibody -induced glucose instability in an elderly woman with type 2 diabetes on hemodialysis, successfully ameliorated with liraglutide [ J ]. Diabe- tology International ,2013,4( 1 ) :71775.
9Sauerborn M, Brinks V, Jiskoot W, et al. Immunological mechanism underlying the immune response to recombinant human protein thera- peutics[ J]. Trends Pharmacol Sei ,2010,31 (2) :53-59.
10Dailey G, Rosenstock J, Moses RG, et al. Insulin glulisine provides improved glycemic control in patients with type 2 diabetes [ J]. Dia- betes Care ,2004.27 ( 10 ) :2363-2368.
